Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897545 · ClinicalTrials.gov registry record · Phase 2
Combined Treatment of Arterial Hypertension and Atrial Fibrillation
A Phase 2 study of Atrial Fibrillation and Arterial Hypertension, sponsored by Meshalkin Research Institute of Pathology of Circulation.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT01897545: Completed Phase 2 study of Atrial Fibrillation and Arterial Hypertension, sponsored by Meshalkin Research Institute of Pathology of Circulation.
NCT01897545 is a Phase 2 study of Atrial Fibrillation and Arterial Hypertension that has completed, run by Meshalkin Research Institute of Pathology of Circulation. The registered enrollment target is 60 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897545, a Phase 2 study of Atrial Fibrillation and Arterial Hypertension, has completed, sponsored by Meshalkin Research Institute of Pathology of Circulation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is the comparative evaluation of systolic blood pressure (SBP) lowering, atrial fibrillation (AF) recurrence and clinical data in patients with paroxysmal/persistent AF and resistant/non-resistant hypertension, undergoing AF ablation alone or combined with percutaneous renal denervation.
Conditions Studied
Interventions
- PROCEDURE Circumferential PV isolation
- PROCEDURE PV isolation+renal denervation
Study Locations (3)
Other
- Athens Euroclinic - Athens
- State Research Institute of Circulation Pathology - Novosibirsk
New York
- The Valley Health System - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
What the finished NCT01897545 record still lists
NCT01897545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Circumferential PV isolation is the first listed.
NCT01897545 reports a single indexed study location in Other, New York.
Frequently Asked Questions
What is clinical trial NCT01897545 about?
NCT01897545 is a clinical study titled "Combined Treatment of Arterial Hypertension and Atrial Fibrillation". The purpose of this study is the comparative evaluation of systolic blood pressure (SBP) lowering, atrial fibrillation (AF) recurrence and clinical data in patients with paroxysmal/persistent AF and resistant/non-resistant hypertension, undergoing AF ablation alone or combined with percutaneous rena...
What is the current status of trial NCT01897545?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2012-04. Estimated completion is 2013-06.
What conditions does trial NCT01897545 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Arterial Hypertension.
What interventions are being tested in trial NCT01897545?
The interventions under investigation include: Circumferential PV isolation (PROCEDURE), PV isolation+renal denervation (PROCEDURE).
Who is sponsoring clinical trial NCT01897545?
This trial is sponsored by Meshalkin Research Institute of Pathology of Circulation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01897545 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01897545's enrollment target sits among peer trials
60 166th of 202 higher than 33 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
RECRUITING · Phase 2
-
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
RECRUITING · Phase 2
-
A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation
RECRUITING · Phase 2
-
ECG Validation Study
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia